Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - CAPITAL EXPENDITURES
Capital Expenditures HALO - Halozyme Therapeutics, Inc.
-10.7 M
LAST VALUE
-49.12%
2 YEAR CAGR
-21.50%
5 YEAR CAGR
-22.83%
10 YEAR CAGR